close search

Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.

Nielsen S, Dietze P, Cantwell K, Lee N, Taylor D

VIEW FULL ARTICLE
  • Journal Journal of substance abuse treatment

  • Published 04 Mar 2008

  • Volume 35

  • ISSUE 4

  • Pagination 457-61

  • DOI 10.1016/j.jsat.2007.12.007

Abstract

This study examined the nature and extent of methadone- and buprenorphine-related morbidity through a retrospective analysis of ambulance service records (N = 243) in Melbourne, Australia. Cases in which methadone and buprenorphine were implicated are examined. Demographic and presenting characteristics, transport outcomes, and other substance use were explored. There were 84 buprenorphine-related attendances and 159 methadone-related attendances recorded on the database over the 4-year period. Presenting signs (respiratory rate and Glasgow Coma Scale score) were lower in the methadone-related attendances. Most of the attendances resulted in transport to hospital. Most presentations did not involve traditional signs of opioid overdose, a finding that warrants further investigation. This is the first article to describe characteristics of methadone- and buprenorphine-related ambulance attendances, with results suggesting this may be a useful way to monitor harms associated with these medications in the future.